Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Creative Medical Technology Holdings (CELZ) Interest Expenses (2016 - 2023)

Creative Medical Technology Holdings (CELZ) has disclosed Interest Expenses for 13 consecutive years, with $50.0 as the latest value for Q1 2023.

  • On a quarterly basis, Interest Expenses changed N/A to $50.0 in Q1 2023 year-over-year; TTM through Dec 2023 was $50.0, a N/A change, with the full-year FY2021 number at $4.3 million, up 247.96% from a year prior.
  • Interest Expenses was $50.0 for Q1 2023 at Creative Medical Technology Holdings, down from $2.4 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $2.4 million in Q4 2021 to a low of $50.0 in Q1 2023.
  • A 4-year average of $569507.8 and a median of $336076.0 in 2021 define the central range for Interest Expenses.
  • Peak YoY movement for Interest Expenses: crashed 45.35% in 2020, then surged 652.38% in 2021.
  • Creative Medical Technology Holdings' Interest Expenses stood at $407544.0 in 2019, then fell by 21.64% to $319354.0 in 2020, then soared by 652.38% to $2.4 million in 2021, then tumbled by 100.0% to $50.0 in 2023.
  • Per Business Quant, the three most recent readings for CELZ's Interest Expenses are $50.0 (Q1 2023), $2.4 million (Q4 2021), and $1.3 million (Q3 2021).